Han­soh grabs $1B wind­fall in the lat­est Chi­na phar­ma IPO to hit the Hong Kong ex­change

Chi­na’s fast-grow­ing phar­ma pow­er­house Han­soh Phar­ma­ceu­ti­cal has raised a bil­lion dol­lars in the lat­est IPO to hit the Hong Kong ex­change. And the green shoe could push that up to $1.15 bil­lion, ac­cord­ing to the Fi­nan­cial Times.

The fi­nan­cial news group re­port­ed that Han­soh hit the top of its range, sell­ing 551 mil­lion shares at $1.82 each. Rough­ly half of that wind­fall will go to R&D, with the oth­er half ear­marked for their man­u­fac­tur­ing, sales and mar­ket­ing or­ga­ni­za­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER